Drug reference

siponimod

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Drug class

Central Nervous System (MS Drugs)

Mechanism of action

Sphingosine-1-phosphate (S1P) receptor modulator, Binds with high affinity to S1P receptors 1 and 5; blocks lymphocyte egress from lymph nodes, reducing the number of lymphocytes in peripheral blood, Mechanism by which siponimod exerts therapeutic effects in MS is unknown, but may involve reduction of lymphocyte migration into the CNS

Common side effects

  • Dizziness
  • Headache
  • Nausea
  • Hypotension
  • Transaminase increased
  • Falls
  • Peripheral edema

Related conditions

Frequently asked questions

What drug class is siponimod?

siponimod belongs to: Central Nervous System.

How does siponimod work?

Sphingosine-1-phosphate (S1P) receptor modulator, Binds with high affinity to S1P receptors 1 and 5; blocks lymphocyte egress from lymph nodes, reducing the number of lymphocytes in peripheral blood, Mechanism by which siponimod exerts therapeutic effects in MS is unknown, but may involve reduction of lymphocyte migration into the CNS

What are the common side effects of siponimod?

Dizziness, Headache, Nausea, Hypotension, Transaminase increased, Falls, Peripheral edema

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug reference